Pseudoprogression Possible in Enzalutamide-Treated mCRPC – Renal and Urology News
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
Doubling of vitamin B12 associated with lower systolic and diastolic blood pressure
Certain metabolic factors are associated with the development of chronic musculoskeletal pain, including higher BMI and the presence of diabetes.
However, glycemic control worsened, with the trend most pronounced among younger adults aged 20 to 44 years
Preservation of residual kidney function is an important goal for patients undergoing dialysis.
Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.
Four weeks after LFBV, intervention group had significantly lower urinary leukocytes, postvoid residual volume, fewer signs and symptoms of UTI
A simple intervention that fast tracks early testing may improve kidney transplantation rates and disparities.
Survey reveals many Americans worry they will incur medical debt if they experience a major medical event
No benefits seen in terms of weight loss, diabetes remission, surgery safety
A systematic review and meta-analysis identified factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents (ESAs).